NCT04555655

The Effects of Chicken Extract and a Peptide Supplement for the Prevention of Cognitive Decline in Non-demented Elderly Adults

Trial of A Chicken Extract and Peptide Supplement for the Prevention of Cognitive Decline and Mechanisms of Action in Non-demented Elderly Adults: A Multicenter, Two-year, Three-arm, Randomized, Double-blind, Placebo-controlled Study

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 276 (actual)
• Sponsor: Brand's Suntory Asia · Industry
• Sex: All
• Age: 55 Years – 75 Years
• Healthy volunteers: Accepted

Summary

This trial investigates the effect of a chicken extract supplement and a peptide supplement on cognitive function and potential mechanisms of action of cognitive decline during ageing, among non-demented elderly adults using a three-arm, randomized, placebo-controlled clinical trial design.

Conditions

• Cognitive Decline
• Mild Cognitive Impairment
• Aging

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Chicken extract supplement	70ml of chicken extract supplement to be consumed daily in the morning before meals for 2 years.
DIETARY_SUPPLEMENT	Peptide Supplement	70ml of Peptide Supplement (670mg) to be consumed daily in the morning before meals for 2 years.
OTHER	Placebo	70ml of placebo (caesinate) to be consumed daily in the morning before meals for 2 years.

Timeline

• Start date: 2020-12-11
• Primary completion: 2024-11-15
• Completion: 2025-01-08
• First posted: 2020-09-21
• Last updated: 2025-09-16

Locations

3 sites across 1 country: Taiwan